National Cancer Control Policy
    • home
    • Preventable risk factors
      • Tobacco control
      • Obesity
      • UV radiation
      • Alcohol and cancer
      • Occupational cancers
    • Screening and immunisation
      • Principles of screening
      • Cancer vaccines
      • Breast cancer
      • Bowel cancer
      • Cervical cancer
      • Liver cancer
      • Prostate cancer
    • Cancer care
      • Drug access and affordability
    • View
    • View source
    • History
    • What links here
    • Related changes
    • Special pages
    • Permanent link
    • Page information
    • Browse properties

    Citation:FUTURE I and II Study Group, Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM, et al 2011

    From National Cancer Control Policy
    Jump to:navigation, search

    FUTURE I and II Study Group, Ault KA, Joura EA, Kjaer SK, Iversen OE, Wheeler CM, et al. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine. Int J Cancer 2011 Mar 15;128(6):1344-53 Available from: http://www.ncbi.nlm.nih.gov/pubmed/20949623.


    Critical appraisals

    • Assign a critical appraisal


    Cited by

    1. Impact
    2. Prevention
    Retrieved from "https://wiki.cancer.org.au/policy_mw/index.php?title=Citation:FUTURE_I_and_II_Study_Group,_Ault_KA,_Joura_EA,_Kjaer_SK,_Iversen_OE,_Wheeler_CM,_et_al_2011&oldid=4484"
    Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.